Commentary

Karen DeYoung, Peter Spiegel, and Giles Whittell join Ivo Daalder to discuss the week's top news stories.

Following high profile pauses to the AstraZeneca and Johnson & Johnson vaccines, as well as surging cases in different parts of the world, it is clear that the gains in some countries do not signal an end to the pandemic.

The Good Friday Accords may have reduced violence, but decades later sectarian tensions still run high.

With high-profile suspensions of the AstraZeneca and Johnson and Johnson vaccine, fear of potential side effects and uneven efficacy of vaccine rollouts are causing concern for some.

Outbreaks continue to emerge even as vaccinations increase; some countries feel safe to engage in more normal activities while others introduce new restrictions.

Bobby Ghosh, Philip Stephens, and Nahal Toosi join Ivo Daalder to discuss the week's top news stories.

Susan Glasser, James Harding, and Peter Spiegel join Ivo Daalder to discuss the week's top news stories.

Ivo Daalder, Chuck Hagel, Malcolm Rifkind, and Kevin Rudd join Brian Hanson to explain why the current security environment could restart nuclear proliferation.

Even as the vaccine rollout continues, some nations consider greater restrictions and further lockdowns as case numbers increase.

Wendy Cutler and Noah Barkin join Brian Hanson to examine how the new investment deal will influence US foreign policy.